Pharmaline has been acquired by Gilde Healthcare Partners
The private shareholders of Pharmaline have sold 55% of their share capital to Gilde Healthcare Partners for an undisclosed consideration.
Pharmaline is specialized in the semi-industrial manufacturing of unregistered pharmacy preparation products. Pharmaline's facilities and production processes are structured to comply with the guidelines of the Dutch Health Care Inspectorate and the Good Manufacturing Practice guidelines, which have been mandatory for a pharmacy preparation production company since 2007. Pharmaline services the Dutch intramural (hospital pharmacies) and extramural (public pharmacies and general practitioner’s pharmacies) pharmacy markets.
Gilde Healthcare Partners is a European venture capital and growth capital firm. The funds focus on companies engaged in the development of novel therapeutics, diagnostics, medical devices and healthcare services.
Oaklins' team in the Netherlands acted as advisor to the seller in this transaction.
Talk to the deal team
Related deals
STM Environmental has been acquired by Phenna Group
STM Environmental has been acquired by Phenna Group, gaining access to a broader network of expertise, enhanced resources and global reach. With extensive experience in life safety, environmental compliance and quality testing, along with a wide client base, Phenna Group is the ideal partner to accelerate STM Environmental’s expansion.
Learn moreDimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn moreAcapo AS has been acquired by Longship AS
Oslo-based intellectual property advisory firm Onsagers, supported by Longship since May 2024, has acquired Acapo AS. By combining decades of expertise and global reach, this strategic acquisition unites two of Norway’s most reputable IP firms, enabling them to offer a comprehensive range of solutions in patents, trademarks and IP strategy. This milestone strengthens their position in building a best-in-class network for strategic IP management, marking a key step in their continued growth.
Learn more